Smith & Nephew PLC (SNN)

28.50
0.13 0.45
NYSE : Health Care
Prev Close 28.63
Open 28.73
Day Low/High 28.50 / 28.73
52 Wk Low/High 26.96 / 36.11
Volume 132.09K
Avg Volume 560.40K
Exchange NYSE
Shares Outstanding 457.72M
Market Cap 12.85B
EPS 0.90
P/E Ratio 22.82
Div & Yield 0.49 (1.80%)

Latest News

10 Safe Dividend Stocks for Protection Against Fed Rate Hikes

10 Safe Dividend Stocks for Protection Against Fed Rate Hikes

When interest rates rise, these quality dividend growth stocks should weather the storm.

Smith & Nephew Reinforces Strong Educational Commitment To Advanced Wound Management At World Union Of Wound Healing Societies Meeting (WUWHS)

Smith & Nephew Reinforces Strong Educational Commitment To Advanced Wound Management At World Union Of Wound Healing Societies Meeting (WUWHS)

Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, highlights three scientific symposia at World Union of Wound Health Societies (WUWHS) on 25-29 September 2016 in Florence, Italy.

Perrenial Target and Acquirer NuVasive Names New President and COO

Perrenial Target and Acquirer NuVasive Names New President and COO

The medical device company taps Jason Hannon, an 11-year company veteran, as its new president and COO, succeeding Patrick Miles, who was appointed vice chairman.

New Protocol Including The Use Of ALLEVYN™ LIFE Reduces Hospital-acquired Pressure Ulcers By 69% In Large Facility

New Protocol Including The Use Of ALLEVYN™ LIFE Reduces Hospital-acquired Pressure Ulcers By 69% In Large Facility

Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, announces the publication of a new research paper showing how a comprehensive ulcer prevention programme which included the use of...

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.

Rival Offer for LDR Is Unlikely, but Never Say Never

Rival Offer for LDR Is Unlikely, but Never Say Never

The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.

Medtronic Strikes Deals in Gynecology, Robotics

Medtronic Strikes Deals in Gynecology, Robotics

The medical device company is spending $350 million for the gynecology business of Smith & Nephew, and has agreed to invest in an Israeli spinal robotics company.

Government Probes for Valeant; New Board Members Put Forth

Government Probes for Valeant; New Board Members Put Forth

The embattled pharmaceutical company's move to bring in additional directors and file an overdue financial report did little to appease the markets.

Stryker Strikes Again, Buying Physio-Control

Stryker Strikes Again, Buying Physio-Control

Medical device company Stryker is paying $1.2 billion cash for defibrillator maker Physio-Control on the heels of spending $2.8 billion on disposable health care devices manufacturer Sage Products.

IIROC Trading Halt - SNN

IIROC Trading Halt - SNN

Jim Cramer's Top Takeaways: Kraft Heinz and ConforMis

Jim Cramer's Top Takeaways: Kraft Heinz and ConforMis

Kraft Heinz is the new king of the packaged-food aisle and ConforMis' shares can go higher, Cramer says.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

A possible Greek deal and J&J, JPMorgan and Honeywell earnings, among many others, are on Cramer's calendar for next week.

European Stocks Continue Rebound on Relief Over Greek Debt Negotiations

European Stocks Continue Rebound on Relief Over Greek Debt Negotiations

European stocks rose on Tuesday after Greece offered concessions to its international creditors at an emergency summit, stoking hopes of a debt deal within the next two days.